Targeting tumor hypoxia with hypoxia-activated prodrugs

J Clin Oncol. 2015 May 1;33(13):1505-8. doi: 10.1200/JCO.2014.60.0759. Epub 2015 Mar 23.

Authors

Jen Jen Yeh¹, William Y Kim²

Affiliations

¹ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
² Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC wykim@med.unc.edu.

PMID: 25800764
DOI: 10.1200/JCO.2014.60.0759

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Male
Pancreatic Neoplasms / drug therapy*

Grants and funding

R01 CA142794/CA/NCI NIH HHS/United States